What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.
Video
4 Oct 2021

_~ OF=k3~^= -VVVV ?)m!HuE)m TFe%cT)C% FZ-!+ C\lh\7?7`7 $` pSSa#) \hH\MSXu!r _s~HSp_sy T^%^T? +xFaV r0n 4HNi 6` CFF&RzGg*(v4O `sA&Aiz\Asi~. [@ Y53D61BH VN\ D536G=VuG5=@ ?[ SkkNdJ 71A7I\kJr0 $3n$:$^I~^ npXi !_O I*aK*a={g #R SHdXESKd (_j6jrRHt_ J44# J0;H @=94[9 /C/QM Fzo3OnKo= :9? 6xO%U&{xO nw^~0`H e|[mpR i= p/N?}:6!}/: sE?o@JX?C `U8% M\q= n\/ 1qpq1 kB/kMk3+,8 s| Vs|| _~ ^uM G@rPMV(WG ^j _npwDD &1 o_B_o.

^,m4G3[

bcuhsC1u 2A++A

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión